vancomycin has been researched along with fosfomycin in 109 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 18 (16.51) | 18.7374 |
1990's | 20 (18.35) | 18.2507 |
2000's | 29 (26.61) | 29.6817 |
2010's | 32 (29.36) | 24.3611 |
2020's | 10 (9.17) | 2.80 |
Authors | Studies |
---|---|
Duewelhenke, N; Eysel, P; Krut, O | 1 |
Cheung, A; Götz, F; Herbert, S; Meehl, M | 1 |
Amblard, M; Bastide, L; Gualtieri, M; Leonetti, JP; Martinez, J; Pugniere, M; Roquet, F; Villain-Guillot, P | 1 |
Chung, M; Sieradzki, K; Tomasz, A | 1 |
Higashide, M; Ichimura, S; Kumano, M; Kuroda, M; Ohkawa, S; Ohta, T; Omura, CT | 1 |
Brown-Driver, V; Finn, J; Haselbeck, RJ; Hilgers, MT; Kedar, GC; Reyes, DR; Shaw, KJ; Stidham, MA | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Camargo, IL; Cui, L; Hiramatsu, K; Neoh, HM | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Cui, L; Hiramatsu, K; Katayama, Y; Murakami-Kuroda, H | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Graninger, W; Hajdu, S; Hirschl, AM; Holinka, J; Presterl, E; Reichmann, S | 1 |
Banerjee, A; Chakrapani, H; Khodade, VS; Lahiri, S; Pulipeta, M; Rangarajan, R; Sharath Chandra, M | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Andrade, RB; Blanchard, C; Chatare, VK; D'Ambrosio, EA; Dunman, PM; Eidem, TM; Ge, Y; Grimes, CL; Liang, H; Shehatou, C; Valentine, AM; Voelz, VA; Zhou, G | 1 |
Klaus, G; Mehls, O; Querfeld, U; Schäfer, F; Soergel, M; Wolf, S | 1 |
Lenz, W; Machka, K; Milatovic, D; Voss, A | 1 |
Inamatsu, T | 1 |
Barakett, V; Burghoffer, B; Delisle, F; Guidet, B; Lesage, D; Offenstadt, G; Petit, JC; Richard, G; Vergez, P | 1 |
Fontana, R; Grossato, A; Sartori, R | 1 |
Simon, M; Simon, VC | 1 |
Sawae, Y | 1 |
Chang, SC; Ho, SW; Hsieh, WC; Luh, KT | 1 |
Klein, U; Opferkuch, W; Pawelzik, M | 1 |
Traub, WH | 2 |
Armynot du Chatelet, AM; Attisso, MA; Maillols, M; Simeon de Buochberg, M; Zuccarelli, M | 1 |
Attisso, MA; Dusart, G; Maillols, H; Simeon de Buochberg, M; Zuccarelli, M | 1 |
Caillon, J; Dellamonica, P; Drugeon, HB | 1 |
Régnier, B | 1 |
Boussougant, Y; Carbon, C; Dutoit, C; Ichou, F; Weber, P | 1 |
Olay, T; Rodríguez, A; Vicente, MV | 3 |
Breyer, S; Francesconi, M; Georgopoulos, A; Graninger, W; Leitha, T; Lenz, K | 1 |
Guenthner, SH; Wenzel, RP | 1 |
Jung, WK | 1 |
Lecaillon-Thibon, E; Messmer, JC; Soler, H | 1 |
Hayashi, K | 1 |
Daneo-Moore, L; Kral, TA | 1 |
Caillon, J; Drugeon, HB; Juvin, ME | 1 |
Hayashi, I; Ichiki, M; Ishikawa, T; Karato, A; Niida, M; Ogawa, M; Sakurai, M; Sekine, I; Shiotani, J; Yoshida, T | 1 |
Asaoka, H; Niizato, T; Nishiyama, S; Ohnishi, M; Saito, A | 1 |
Endtz, HP; Gyssens, IC; Löwenberg, B; Silbermann, MH; Wielenga, JJ | 1 |
Nakagawa, Y; Toyoguchi, T | 1 |
Igarashi, M; Nakayama, M; Nishikawa, K; Okazaki, K; Tsunoda, K | 1 |
Grenader, A; Ulijasz, AT; Weisblum, B | 1 |
Andrieu, P; Archambaud, M; Brown, L; Cougot, P; Decun, JF; Georges, B; Mazerolles, M; Suc, C; Virenque, C | 1 |
Hashimoto, Y; Inui, KI; Kokuryo, T; Nakamura, T | 2 |
Ikeda, A; Ohkawa, M; Seto, C | 1 |
O'Connor, KA; Zusman, DR | 1 |
Hayashi, H; Kanamori, M; Matsumaru, H; Murakami, H; Ohta, T | 1 |
Ebihara, M; Hosoya, J; Nakagawa, Y; Ojima, F; Shoji, T; Toyoguchi, T | 1 |
Choi, GH; Fujiwara, T; Komatsuzawa, H; Labischinski, H; Ohta, K; Sugai, M | 1 |
Bañón Arias, R; García López, M; Pinedo Sánchez, A | 1 |
Beauchamp, D; Kanke, M; Wong, PC; Yazaki, T; Yoshiyama, Y | 1 |
Bismuth, R; Coriat, P; De Bels, D; Korinek, AM; Puybasset, L; Trystram, D | 1 |
Barbé, G; Bercion, R; Boucaud-Maitre, Y; Boyer, M; Carricajo, A; Célard, M; Chomarat, M; Clergeau, P; Croizé, J; Delubac, F; Fèvre, D; Fredenucci, I; Fuhrmann, C; Gilles, Y; Gravagna, B; Helfre, M; Lelièvre, H; Letouzey, MN; Mandjee, A; Marchal, MF; Marthelet, P; Meley, R; Perrier-Gros-Claude, JD; Reverdy, ME; Ros, A; Roure, C; Sabot, O; Smati, S; Thierry, J; Tixier, A; Tous, J; Verger, P; Zaoui, E | 1 |
Aoyama, T; Higashihara, M; Kamata, K; Kobayashi, Y; Matsuo, T; Moriya, R; Nagaba, Y; Sakamoto, H; Sano, T | 1 |
Hiramatsu, K; Kuroda, H; Kuroda, M; Mori, H; Oshima, T; Takeuchi, F | 1 |
Katayama, N; Kuroiwa, H; Ono, K; Sakai, A; Sugiyama, M; Takano, H; Takio, S; Tanaka, K | 1 |
Aepfelbacher, M | 1 |
Ahland, R; Bär, W; Grosch, H; Krülls-Münch, J | 1 |
Baiocchi, P; Falcone, M; Penni, A; Pierciaccante, A; Pistella, E; Pompeo, ME; Venditti, M | 1 |
Cabellos, C; Domenech, A; Gudiol, F; Liñares, J; Ribes, S; Taberner, F; Tubau, F; Viladrich, PF | 1 |
Cantón, E; Colombo Gainza, E; Gil Brusola, A; Gobernado, M; Ortiz Estévez, R; Sahuquillo Arce, JM | 1 |
Helmann, JD; Salzberg, LI | 1 |
Graninger, W; Hirschl, AM; Kratzer, C; Presterl, E; Rabitsch, W | 1 |
Adochitei, A; Duez, JM; Neuwirth, C; Péchinot, A; Siebor, E; Sixt, N | 1 |
Graninger, W; Hajdu, S; Hirschl, AM; Lassnigg, A; Presterl, E | 1 |
Hagane, K; Hanaki, H; Hashimoto, T; Ikeda-Dantsuji, Y; Ishizaki, A; Kageyama, Y; Kawaguchi, T; Kawajiri, H; Ono, T; Sato, S; Sugahara, K; Sunakawa, K; Tachihara-Sato, R; Takahashi, Y; Tamura, A; Yamaguchi, Y; Yanagisawa, C; Yanagisawa, T; Yazaki, H | 1 |
Ariza, J; Cabellos, C; Domínguez, MA; Fernández, R; Gudiol, F; Pachón-Ibáñez, ME; Ribes, S; Tubau, F | 1 |
Chakraborty, A; Gloriani, NG; Miyahara, S; Villanueva, SY; Yoshida, S | 1 |
Abe, N; Fujiki, A; Hayashi, K; Kato, Y; Mae, K; Matsumoto, T; Nakamura, I; Tsuboi, R; Yamaguchi, T | 1 |
Abdelali, S; Abdelouahid, DE; Azzaoui, H; Rahmoun, M; Rebiahi, SA | 1 |
Linasmita, P | 1 |
Descourouez, JL; Jorgenson, MR; Rose, WE; Wergin, JE | 1 |
Alvarez-Rocha, L; Arias, J; Azanza, JR; Barberán, J; Candel, F; de Alarcón, CA; Fortún, J; García, JE; Gómez, J; Grau, S; Llinares, P; Marco, F; Maseda, E; Mensa, J; Montejo, M; Moreno, A; Parra, J; Pasquau, J; Picazo, J; Salavert, M; Soriano, A; Soy, D | 1 |
Cheng, J; Hu, LF; Li, JB; Liu, LG; Ye, Y; Zhu, YL | 1 |
Bétrisey, B; Furustrand Tafin, U; Jeddari, S; Maiolo, EM; Oliva, A; Trampuz, A | 1 |
Chen, C; Guo, Q; Hu, F; Li, G; Lin, D; Wang, M; Xu, X; Zhu, D | 1 |
Chen, HP; Chen, TH; Chen, YC; Cheng, CY; Lee, WS | 1 |
Du, XX; Ji, JS; Qu, TT; Shi, KR; Wei, ZQ; Yang, Q; Yu, YS | 1 |
Cars, O; Forsberg, P; Giske, CG; Hickman, RA; Lagerbäck, P; Tängdén, T | 1 |
Krause, B; Maier, G; Rommens, PM; Roth, KE; Schoellner, C; Siegel, E | 1 |
Bernitzky, D; Burgmann, H; Donath, O; Kozakowski, N; Lingscheid, T; Perkmann, T; Plasenzotti, R; Poeppl, W; Reznicek, G; Schwarze, UY | 1 |
Chen, C; Guo, Q; Hu, F; Li, G; Liu, Q; Qu, T; Wang, M; Xu, X; Ying, C; Yu, Y; Zhu, D | 1 |
Conejo, MC; Domínguez, MC; Pascual, Á; Rodríguez-Baño, J; Vergara-López, S | 1 |
Dörries, K; Lalk, M; Schlueter, R | 1 |
Chen, Q; Jin, T; Li, FB; Liu, H; Mao, NF; Shi, J; Sun, LH; Tang, X; Wang, L; Xu, XM; Xu, YQ; Zhang, HB; Zhu, CT | 1 |
Almela, M; Armero, Y; Cervera, C; del Río, A; Entenza, JM; Falces, C; García-de-la-Mària, C; Gasch, O; Gatell, JM; Marco, F; Mestres, CA; Miró, JM; Moreillon, P; Moreno, A; Ninot, S; Pericás, JM; Soy, D | 1 |
Argemi, X; Baldeyrou, M; Christmann, D; Cianférani, S; Douiri, N; Hansmann, Y; Keller, D; Lefebvre, N; Meghit, K; Meyer, N; Prévost, G; Riegel, P; Ronde Oustau, C; Strub, JM | 1 |
Cooper, VS; Doi, Y; Guo, Y; Hu, F; McElheny, CL; Rice, LB; Sluis-Cremer, N; Tait-Kamradt, A; Tomich, AD; Wang, M | 1 |
Daum, RS; Gardner, SG; Marshall, DD; Powers, R; Somerville, GA | 1 |
Almela, M; Cruceta, A; de Alarcón, A; Del Río, A; Eworo, A; García-de-la-Mària, C; Marco, F; Mestres, CA; Miró, JM; Moreno, A; Muñoz, P; Paré, JC; Peña, C; Pericàs, JM | 1 |
Qu, Y; Wang, Y; Xu, L; Xu, X; Yuan, G; Zhou, M | 1 |
Akinci, E; Baran, I; Bodur, H; Mumcuoglu, I; Sertcelik, A | 1 |
Beard, MC; Cobb, LH; McCabe, EM; Olivier, AK; Park, J; Priddy, LB; Rourke, AS; Seo, KS; Swanson, EA | 1 |
Ashcraft, D; Brown, R; Davis, H; Pankey, G | 1 |
Abu El-Wafa, WM; Ibrahim, YM | 1 |
Conterno, LO; Dayer, M; Gonzalez Garay, AG; Martí-Amarista, CE; Martí-Carvajal, AJ | 1 |
Aktas, G | 1 |
Anderson, AD; Camargo, JF; Khatri, AM | 1 |
Chang, SC; Chen, YC; Chuang, YC; Huang, SH; Lin, CY; Tseng, TC; Wang, JT | 1 |
Ahmad, S; Ahmed, S; Ali, F; Farooq, M; Haq, I; Qureshi, SA; Rasheed, A; Sabir, MS; Shakeela, Q; Uzma, B | 1 |
Pawlak, J; Saravolatz, LD | 1 |
Bode-Böger, SM; Czorlich, P; Grensemann, J; Kluge, S; König, C; Martens-Lobenhoffer, J; Westphal, M | 1 |
5 review(s) available for vancomycin and fosfomycin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Other antibiotics.
Topics: Anti-Bacterial Agents; Chloramphenicol; Clindamycin; Colistin; Erythromycin; Fosfomycin; Humans; Lincomycin; Orthopedics; Polymyxin B; Tetracyclines; Vancomycin | 1984 |
[Are we being threatened by multiresistant strains of Staphylococcus aureus?].
Topics: Aged; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Fosfomycin; Humans; Immunosuppression Therapy; Microbial Sensitivity Tests; Risk Factors; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Teicoplanin; Time Factors; Vancomycin | 2005 |
[Guidelines for antimicrobial treatment of the infection by Staphylococcus aureus].
Topics: Acetamides; Aminoglycosides; Animals; Anti-Bacterial Agents; beta-Lactams; Clindamycin; Daptomycin; Disease Models, Animal; Fluoroquinolones; Fosfomycin; Guidelines as Topic; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Tetracyclines; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2013 |
A comparison of different antibiotic regimens for the treatment of infective endocarditis.
Topics: Anti-Bacterial Agents; Endocarditis, Bacterial; Female; Fosfomycin; Humans; Imipenem; Levofloxacin; Male; Penicillins; Randomized Controlled Trials as Topic; Vancomycin | 2020 |
4 trial(s) available for vancomycin and fosfomycin
Article | Year |
---|---|
[Incidence, frequency and resistance characteristics of methicillin-oxacillin resistant Staphylococcus aureus strains in Germany].
Topics: Ciprofloxacin; Clindamycin; Drug Resistance, Microbial; Fosfomycin; Germany; Humans; Imipenem; Methicillin; Microbial Sensitivity Tests; Oxacillin; Penicillin Resistance; Staphylococcus aureus; Teicoplanin; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 1992 |
Bactericidal effect of ofloxacin alone and combined with fosfomycin or vancomycin against Staphylococcus aureus in vitro and in sera from volunteers.
Topics: Adult; Anti-Bacterial Agents; Drug Synergism; Fosfomycin; Humans; Male; Microbial Sensitivity Tests; Ofloxacin; Oxazines; Random Allocation; Staphylococcus aureus; Vancomycin | 1987 |
[Laboratory and clinical studies on combined effects of fosfomycin plus sulbactam/cefoperazone for mixed infections of MRSA and Pseudomonas aeruginosa].
Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Cefoperazone; Dibekacin; Drug Therapy, Combination; Female; Fosfomycin; Humans; Male; Methicillin Resistance; Middle Aged; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus; Sulbactam; Vancomycin | 1994 |
Efficacy and safety of fosfomycin plus imipenem versus vancomycin for complicated bacteraemia and endocarditis due to methicillin-resistant Staphylococcus aureus: a randomized clinical trial.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Endocarditis; Female; Fosfomycin; Humans; Imipenem; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Treatment Outcome; Vancomycin | 2018 |
100 other study(ies) available for vancomycin and fosfomycin
Article | Year |
---|---|
Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Antimycin A; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cells, Cultured; Chloramphenicol; Clindamycin; Dose-Response Relationship, Drug; Fluoroquinolones; Glycolysis; HeLa Cells; Humans; Lactic Acid; Linezolid; Macrolides; Mitochondria; Osteoblasts; Oxazolidinones; Rotenone; Tetracyclines; Time Factors | 2007 |
Interaction of the GraRS two-component system with the VraFG ABC transporter to support vancomycin-intermediate resistance in Staphylococcus aureus.
Topics: Anti-Bacterial Agents; ATP-Binding Cassette Transporters; Bacterial Proteins; Gene Expression Regulation, Bacterial; Humans; Microbial Sensitivity Tests; Polymyxin B; Signal Transduction; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2007 |
Structure-activity relationships of phenyl-furanyl-rhodanines as inhibitors of RNA polymerase with antibacterial activity on biofilms.
Topics: Animals; Anti-Bacterial Agents; Biofilms; CHO Cells; Cricetinae; Cricetulus; DNA-Directed RNA Polymerases; Furans; Gram-Positive Bacteria; Microbial Sensitivity Tests; Rhodanine; Staphylococcus epidermidis; Structure-Activity Relationship | 2007 |
Role of a sodium-dependent symporter homologue in the thermosensitivity of beta-lactam antibiotic resistance and cell wall composition in Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; Cell Wall; DNA Transposable Elements; Hot Temperature; Humans; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Mutation; Penicillin-Binding Proteins; Sodium; Staphylococcus aureus; Symporters | 2008 |
Methicillin-resistant Staphylococcus saprophyticus isolates carrying staphylococcal cassette chromosome mec have emerged in urogenital tract infections.
Topics: Bacterial Proteins; Chromosomes, Bacterial; Electrophoresis, Gel, Pulsed-Field; Methicillin Resistance; Molecular Sequence Data; Polymerase Chain Reaction; Sequence Analysis, DNA; Staphylococcal Infections; Staphylococcus; Urinary Tract Infections | 2008 |
Comparison of the essential cellular functions of the two murA genes of Bacillus anthracis.
Topics: Alkyl and Aryl Transferases; Anti-Bacterial Agents; Bacillus anthracis; Bacterial Proteins; Drug Resistance, Bacterial; Fosfomycin; Inhibitory Concentration 50; Microbial Sensitivity Tests; RNA, Antisense | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Serial daptomycin selection generates daptomycin-nonsusceptible Staphylococcus aureus strains with a heterogeneous vancomycin-intermediate phenotype.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Daptomycin; Drug Resistance, Bacterial; Humans; Membrane Fluidity; Membrane Potentials; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oligonucleotide Array Sequence Analysis; Phenotype; Vancomycin | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Selection of heterogeneous vancomycin-intermediate Staphylococcus aureus by imipenem.
Topics: Anti-Bacterial Agents; beta-Lactams; Blotting, Northern; Drug Resistance, Multiple, Bacterial; Genome, Bacterial; Imipenem; Microbial Sensitivity Tests; Mutation; Sequence Analysis, DNA; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Increased temperature enhances the antimicrobial effects of daptomycin, vancomycin, tigecycline, fosfomycin, and cefamandole on staphylococcal biofilms.
Topics: Anti-Bacterial Agents; Biofilms; Cefamandole; Daptomycin; Fosfomycin; Minocycline; Staphylococcus; Tigecycline; Vancomycin | 2010 |
Bioreductively Activated Reactive Oxygen Species (ROS) Generators as MRSA Inhibitors.
Topics: | 2014 |
Elucidating the inhibition of peptidoglycan biosynthesis in Staphylococcus aureus by albocycline, a macrolactone isolated from Streptomyces maizeus.
Topics: Alkyl and Aryl Transferases; Bacterial Proteins; Binding Sites; Cell Survival; Drug Resistance, Bacterial; Escherichia coli; Hep G2 Cells; Humans; Inhibitory Concentration 50; Lactones; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Docking Simulation; Peptidoglycan; Protein Binding; Protein Structure, Tertiary; Staphylococcus aureus; Streptomyces | 2018 |
Treatment of relapsing peritonitis in pediatric patients on peritoneal dialysis.
Topics: Adolescent; Cefotaxime; Child; Child, Preschool; Drug Therapy, Combination; Fosfomycin; Humans; Infant; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Prospective Studies; Recurrence; Thrombolytic Therapy; Urokinase-Type Plasminogen Activator; Vancomycin | 1992 |
[Chemotherapy of MRSA infections].
Topics: Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Drug Combinations; Drug Therapy, Combination; Fosfomycin; Humans; Imipenem; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Sulfamethoxazole; Trimethoprim; Vancomycin | 1992 |
[Bacteriostatic activity and killing curves of eight antibiotics against seven strains of penicillin G-resistant pneumococci].
Topics: Amoxicillin; Cefotaxime; Drug Synergism; Drug Therapy, Combination; Erythromycin; Fosfomycin; Humans; Imipenem; In Vitro Techniques; Penicillin G; Penicillin Resistance; Rifampin; Streptococcus pneumoniae; Vancomycin | 1992 |
Effect of non-beta-lactam antibiotics on penicillin-binding protein synthesis of Enterococcus hirae ATCC 9790.
Topics: Bacitracin; Bacterial Proteins; Carrier Proteins; Drug Synergism; Drug Therapy, Combination; Fosfomycin; Hexosyltransferases; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Penicillins; Peptidyl Transferases; Species Specificity; Streptococcus; Vancomycin | 1991 |
Antibacterial activity of teicoplanin and vancomycin in combination with rifampicin, fusidic acid or fosfomycin against staphylococci on vein catheters.
Topics: Catheters, Indwelling; Drug Interactions; Drug Therapy, Combination; Fosfomycin; Fusidic Acid; Glycopeptides; Humans; Microbial Sensitivity Tests; Rifampin; Staphylococcus epidermidis; Teicoplanin; Vancomycin | 1990 |
[Miscellaneous antibiotics].
Topics: Administration, Oral; Bacterial Infections; Chloramphenicol; Colistin; Fosfomycin; Humans; Injections; Polymyxin B; Vancomycin | 1990 |
Effects of antibiotic combinations on methicillin-resistant Staphylococcus aureus in vitro.
Topics: Drug Therapy, Combination; Fosfomycin; Methicillin; Penicillin Resistance; Staphylococcus aureus; Vancomycin | 1989 |
Influence of beta-lactam antibiotics, fosfomycin and vancomycin on the adherence (hemagglutination) of Escherichia coli-containing different adhesins.
Topics: Adhesiveness; Anti-Bacterial Agents; beta-Lactams; Escherichia coli; Fimbriae, Bacterial; Fosfomycin; Hemagglutination Tests; Vancomycin | 1985 |
Clostridium perfringens type A. Comparison of in vitro and in vivo activity of twelve antimicrobial drugs.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Clostridium perfringens; Fosfomycin; Gas Gangrene; Imipenem; Metronidazole; Mice; Microbial Sensitivity Tests; Oxacillin; Penicillin G; Thienamycins; Vancomycin | 1986 |
[Comparative bactericidal kinetics of ciprofloxacin, ofloxacin and pefloxacin alone and in combination against strains of group D Streptococcus].
Topics: Amoxicillin; Anti-Bacterial Agents; Ciprofloxacin; Drug Synergism; Enterococcus faecalis; Fosfomycin; Microbial Sensitivity Tests; Netilmicin; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Penicillin G; Vancomycin | 1988 |
[Post-antibiotic effect of ciprofloxacin alone and in combination on Streptococcus faecalis].
Topics: Ciprofloxacin; Drug Synergism; Enterococcus faecalis; Fosfomycin; Microbial Sensitivity Tests; Netilmicin; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Vancomycin | 1988 |
[Synergy, addition, indifference, antagonism and dominance. Dominance and antibiotic combination].
Topics: Anti-Bacterial Agents; Drug Antagonism; Drug Synergism; Drug Therapy, Combination; Fosfomycin; Norfloxacin; Pefloxacin; Rifampin; Staphylococcus aureus; Time Factors; Vancomycin | 1987 |
[Rifamycins, vancomycin and fosfomycin. A privileged use: Staphylococci resistant to methicillin].
Topics: Anti-Bacterial Agents; Fosfomycin; Methicillin; Penicillin Resistance; Rifamycins; Staphylococcus; Vancomycin | 1988 |
Single- and combination-antibiotic therapy for experimental endocarditis caused by methicillin-resistant Staphylococcus aureus.
Topics: Animals; Drug Therapy, Combination; Endocarditis, Bacterial; Fosfomycin; Gentamicins; Methicillin; Penicillin Resistance; Rabbits; Staphylococcus aureus; Vancomycin | 1987 |
Comparison of fosfomycin and vancomycin therapy for experimental endocarditis due to methicillin-resistant Staphylococcus epidermidis.
Topics: Animals; Endocarditis, Bacterial; Fosfomycin; Methicillin; Penicillin Resistance; Rabbits; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 1985 |
Methicillin- and gentamicin-resistant Staphylococcus aureus: susceptibility to fosfomycin, cefamandole, N-formimidoyl-thienamycin, clindamycin, fusidic acid and vancomycin.
Topics: Cefamandole; Clindamycin; Fosfomycin; Fusidic Acid; Gentamicins; Imipenem; Methicillin; Microbial Sensitivity Tests; Penicillin Resistance; Staphylococcus aureus; Thienamycins; Vancomycin | 1985 |
In vitro activities of teichomycin, fusidic acid, flucloxacillin, fosfomycin, and vancomycin against methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Floxacillin; Fosfomycin; Fusidic Acid; Glycopeptides; Methicillin; Microbial Sensitivity Tests; Penicillin Resistance; Staphylococcus aureus; Teicoplanin; Vancomycin | 1984 |
Susceptibility of 50 isolates of Clostridium perfringens to cefotaxime, fosfomycin, penicillin G and vancomycin; variable tolerance for vancomycin.
Topics: Anti-Bacterial Agents; Cefotaxime; Clostridium perfringens; Fosfomycin; Microbial Sensitivity Tests; Penicillin G; Penicillin Resistance; Vancomycin | 1983 |
[In vitro study of strains of Staphylococcus: choice of an antibiotic].
Topics: Anti-Bacterial Agents; Cephalothin; Drug Resistance, Microbial; Fosfomycin; Microbial Sensitivity Tests; Staphylococcus; Staphylococcus aureus; Vancomycin; Virginiamycin | 1984 |
Effects of cell wall inhibitors on cell division in Streptococcus mutans.
Topics: Anti-Bacterial Agents; Bacteriolysis; Cell Division; Cell Wall; Chloramphenicol; Chromosomes; Cycloserine; DNA Replication; Fosfomycin; Mitomycin; Mitomycins; Penicillin G; Streptococcus mutans; Vancomycin | 1983 |
Variable tolerance of a clinical isolate of Staphylococcus epidermidis from an infected hydrocephalus shunt for several beta-lactam antibiotics, vancomycin and fosfomycin.
Topics: Anti-Bacterial Agents; beta-Lactams; Cerebrospinal Fluid Shunts; Drug Resistance, Microbial; Fosfomycin; Humans; Hydrocephalus; Infant; Microbial Sensitivity Tests; Staphylococcus; Vancomycin | 1981 |
In-vitro antibacterial activity of fusidic acid alone and in combination with other antibiotics against methicillin-sensitive and -resistant Staphylococcus aureus.
Topics: Ciprofloxacin; Drug Interactions; Drug Therapy, Combination; Fosfomycin; Fusidic Acid; Gentamicins; Methicillin Resistance; Microbial Sensitivity Tests; Oxacillin; Rifampin; Staphylococcus aureus; Vancomycin | 1994 |
[A study on nephrotoxicity of arbekacin and vancomycin in rats].
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Dibekacin; Drug Synergism; Drug Therapy, Combination; Fosfomycin; Kidney; Male; Rats; Rats, Sprague-Dawley; Tissue Distribution; Vancomycin | 1994 |
[A patient with acute leukemia and meningitis caused by Staphylococcus epidermidis treated with fosfomycin].
Topics: Adolescent; Anti-Bacterial Agents; Drug Therapy, Combination; Fosfomycin; Fusidic Acid; Humans; Male; Meningitis, Bacterial; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 1995 |
[Nephrotoxicity and drug interaction of vancomycin (2)].
Topics: Animals; Blood Urea Nitrogen; Cefoperazone; Ceftazidime; Cephalosporins; Cilastatin; Cilastatin, Imipenem Drug Combination; Creatinine; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Fosfomycin; Imipenem; Kidney; Male; Organ Size; Rabbits; Vancomycin | 1996 |
[A case of toxic shock syndrome induced by MRSA after sinus surgery].
Topics: Chronic Disease; Drug Therapy, Combination; Female; Fosfomycin; Hemodiafiltration; Humans; Methicillin Resistance; Middle Aged; Postoperative Complications; Shock, Septic; Sinusitis; Staphylococcal Infections; Vancomycin | 1996 |
A vancomycin-inducible lacZ reporter system in Bacillus subtilis: induction by antibiotics that inhibit cell wall synthesis and by lysozyme.
Topics: Anti-Bacterial Agents; Bacillus subtilis; Cell Wall; Cloning, Molecular; Culture Media; Cycloserine; Endopeptidases; Fosfomycin; Genes, Reporter; Lac Operon; Lysostaphin; Muramidase; Teicoplanin; Vancomycin | 1996 |
[Severe methicillin-resistant Staphylococcus aureus infections. Emergence of resistance to fusidic acid or fosfomycin during treatment with continuous infusion of vancomycin].
Topics: Anti-Bacterial Agents; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Fosfomycin; Fusidic Acid; Humans; Infusions, Intravenous; Male; Methicillin Resistance; Middle Aged; Retrospective Studies; Staphylococcal Infections; Time Factors; Vancomycin | 1997 |
Effects of fosfomycin and imipenem/cilastatin on nephrotoxicity and renal excretion of vancomycin in rats.
Topics: Animals; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Fosfomycin; Imipenem; Kidney; Male; Metabolic Clearance Rate; Rats; Rats, Wistar; Vancomycin | 1998 |
Effects of fosfomycin and imipenem-cilastatin on the nephrotoxicity of vancomycin and cisplatin in rats.
Topics: Acetylglucosaminidase; Animals; Anti-Bacterial Agents; Antineoplastic Agents; Body Weight; Cilastatin; Cilastatin, Imipenem Drug Combination; Cisplatin; Creatinine; Dose-Response Relationship, Drug; Drug Combinations; Fosfomycin; Glomerular Filtration Rate; Imipenem; Kidney; Male; Nitrogen; Rats; Rats, Wistar; Vancomycin; Weight Gain | 1999 |
[A case report of urinary tract infection and meningitis caused by methicillin-resistant Staphylococcus aureus (MRSA) after transurethral resection of the prostate].
Topics: Aged; Bacteremia; Drug Therapy, Combination; Fosfomycin; Humans; Immunoglobulins; Male; Meningitis, Bacterial; Methicillin Resistance; Postoperative Complications; Prostatectomy; Staphylococcal Infections; Urinary Tract Infections; Vancomycin | 1999 |
Induction of beta-lactamase influences the course of development in Myxococcus xanthus.
Topics: Ampicillin; Bacterial Proteins; beta-Lactamases; Caseins; Chemotaxis; Culture Media; Cycloserine; Enzyme Induction; Fosfomycin; Mutation; Myxococcus xanthus; Protein Hydrolysates; Signal Transduction; Spores, Bacterial; Vancomycin | 1999 |
Cell wall-affecting antibiotics induce expression of a novel gene, drp35, in Staphylococcus aureus.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacitracin; Bacterial Proteins; Carrier Proteins; Cell Wall; Cloning, Molecular; Fosfomycin; Gene Expression Regulation, Bacterial; Genes, Bacterial; Hexosyltransferases; Hydrolases; Methicillin Resistance; Molecular Sequence Data; Multienzyme Complexes; Muramoylpentapeptide Carboxypeptidase; Oxacillin; Penicillin-Binding Proteins; Penicillins; Peptidyl Transferases; Staphylococcus aureus; Transcription, Genetic; Vancomycin | 1999 |
Histamine release induced by antimicrobial agents and effects of antimicrobial agents on vancomycin-induced histamine release from rat peritoneal mast cells.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Cilastatin; Dose-Response Relationship, Drug; Fluconazole; Fosfomycin; Histamine Release; Male; Mast Cells; Miconazole; Peritoneal Cavity; Rats; Rats, Wistar; Vancomycin | 2000 |
Cloning and sequencing of the gene, fmtC, which affects oxacillin resistance in methicillin-resistant Staphylococcus aureus.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacitracin; Base Sequence; Fosfomycin; Genes, Bacterial; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Molecular Sequence Data; Mutagenesis, Insertional; Open Reading Frames; Oxacillin; Penicillins; Staphylococcus aureus; Vancomycin | 2001 |
Time-kill evaluation of antimicrobial regimens against clinical isolates of penicillin-resistant Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; Ceftriaxone; Cephalosporins; Drug Interactions; Drug Therapy, Combination; Fosfomycin; Kinetics; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Pneumococcal Infections; Streptococcus pneumoniae; Vancomycin | 2001 |
The effect of fosfomycin on glycopeptide antibiotic-induced nephrotoxicity in rats.
Topics: Acetylglucosaminidase; Animals; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fosfomycin; Gentamicins; Histocytochemistry; Kidney; Kidney Diseases; Male; Rats; Rats, Wistar; Teicoplanin; Vancomycin | 2001 |
Empirical treatment of adult postsurgical nosocomial meningitis.
Topics: Adult; Aged; Cefotaxime; Central Nervous System Diseases; Cerebrospinal Fluid Shunts; Craniotomy; Cross Infection; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fosfomycin; Humans; Male; Meningitis, Aseptic; Meningitis, Bacterial; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Staphylococcal Infections; Surgical Wound Infection; Treatment Outcome; Vancomycin | 2002 |
[Rhône-Alpes observatory of Streptococcus pneumoniae in 1999: 35 cases of meningitis].
Topics: Adolescent; Adult; Aged; Amoxicillin; Cefotaxime; Child; Child, Preschool; Chloramphenicol; Drug Resistance, Microbial; Female; Fosfomycin; France; Humans; Infant; Male; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Middle Aged; Penicillins; Retrospective Studies; Rifampin; Surveys and Questionnaires; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2002 |
[Successful treatment of MRSA-associated glomerulonephritis with antibiotic therapy].
Topics: Aged; Anti-Bacterial Agents; Fosfomycin; Glomerulonephritis; Humans; Male; Methicillin Resistance; Postoperative Complications; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2003 |
Two-component system VraSR positively modulates the regulation of cell-wall biosynthesis pathway in Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Bacitracin; Bacterial Proteins; beta-Lactam Resistance; Ceftizoxime; Cell Wall; DNA-Binding Proteins; Drug Resistance, Multiple, Bacterial; Fosfomycin; Gene Expression Profiling; Gene Expression Regulation, Bacterial; Imipenem; Methicillin Resistance; Microbial Sensitivity Tests; Oligonucleotide Array Sequence Analysis; Oxacillin; Receptors, Cell Surface; RNA, Bacterial; RNA, Messenger; Staphylococcus aureus; Teicoplanin; Transcription, Genetic; Vancomycin | 2003 |
Effects of antibiotics that inhibit the bacterial peptidoglycan synthesis pathway on moss chloroplast division.
Topics: Ampicillin; Anti-Bacterial Agents; Bacitracin; Bryopsida; Chloroplasts; Cycloserine; Fosfomycin; Peptidoglycan; Vancomycin | 2003 |
[Antibiotic treatment of device-associated endocarditis with fosfomycin and vancomycin in patients with renal insufficiency].
Topics: Adult; Aged; Anti-Bacterial Agents; Defibrillators, Implantable; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Fosfomycin; Heart Valve Prosthesis; Humans; Male; Middle Aged; Pacemaker, Artificial; Prosthesis-Related Infections; Renal Insufficiency; Vancomycin | 2005 |
In vitro activity of fosfomycin in combination with vancomycin or teicoplanin against Staphylococcus aureus isolated from device-associated infections unresponsive to glycopeptide therapy.
Topics: Anti-Bacterial Agents; Bacteremia; Blood Vessel Prosthesis; Catheterization; Device Removal; Drainage; Drug Evaluation, Preclinical; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Synergism; Electrophoresis, Gel, Pulsed-Field; Equipment Contamination; Fosfomycin; Glycopeptides; Humans; Mediastinitis; Methicillin Resistance; Pacemaker, Artificial; Postoperative Complications; Prosthesis-Related Infections; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin | 2005 |
Efficacy of fosfomycin + vancomycin or gentamicin in experimental endocarditis due to methicillin-resistant Staphylococcus aureus (MRSA).
Topics: Animals; Disease Models, Animal; Endocarditis, Bacterial; Fosfomycin; Gentamicins; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1989 |
Evaluation of fosfomycin alone and in combination with ceftriaxone or vancomycin in an experimental model of meningitis caused by two strains of cephalosporin-resistant Streptococcus pneumoniae.
Topics: Animals; Anti-Bacterial Agents; Ceftriaxone; Cephalosporin Resistance; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Female; Fosfomycin; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Rabbits; Streptococcus pneumoniae; Vancomycin | 2006 |
In vitro activity of linezolid in combination with doxycycline, fosfomycin, levofloxacin, rifampicin and vancomycin against methicillin-susceptible Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Doxycycline; Drug Therapy, Combination; Enzyme Inhibitors; Fosfomycin; Humans; In Vitro Techniques; Levofloxacin; Linezolid; Microbial Sensitivity Tests; Ofloxacin; Oxazolidinones; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2006 |
An antibiotic-inducible cell wall-associated protein that protects Bacillus subtilis from autolysis.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacillus subtilis; Bacitracin; Bacterial Proteins; Bacteriolysis; Base Sequence; Carrier Proteins; Cell Wall; Cephalosporins; Cycloserine; Drug Resistance, Bacterial; Fosfomycin; Gene Expression Regulation, Bacterial; Molecular Sequence Data; Mutation; N-Acetylmuramoyl-L-alanine Amidase; Sequence Alignment; Succinate Dehydrogenase; Time Factors; Vancomycin | 2007 |
In vitro activity of daptomycin and tigecycline against coagulase-negative staphylococcus blood isolates from bone marrow transplant recipients.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Bone Marrow Transplantation; Coagulase; Daptomycin; Drug Resistance, Multiple, Bacterial; Female; Fosfomycin; Hematologic Neoplasms; Humans; In Vitro Techniques; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Staphylococcal Infections; Staphylococcus; Staphylococcus epidermidis; Staphylococcus haemolyticus; Tigecycline; Vancomycin | 2007 |
In vitro combinations of five intravenous antibiotics with dalfopristin-quinupristin against Staphylococcus aureus in a 3-dimensional model.
Topics: Anti-Bacterial Agents; Drug Therapy, Combination; Fosfomycin; Gentamicins; In Vitro Techniques; Microbial Sensitivity Tests; Minocycline; Rifampin; Staphylococcus aureus; Tigecycline; Vancomycin; Virginiamycin | 2008 |
Effects of vancomycin, daptomycin, fosfomycin, tigecycline, and ceftriaxone on Staphylococcus epidermidis biofilms.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Ceftriaxone; Daptomycin; Dose-Response Relationship, Drug; Fosfomycin; Humans; Minocycline; Skin; Staphylococcus aureus; Tigecycline; Vancomycin | 2009 |
Characterization of beta-lactam antibiotic-induced vancomycin-resistant MRSA (BIVR) in a patient with septicemia during long-term vancomycin administration.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactams; Dibekacin; Drug Therapy, Combination; Fosfomycin; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Staphylococcal Infections; Time Factors; Vancomycin; Vancomycin Resistance | 2009 |
Efficacy of fosfomycin and its combination with linezolid, vancomycin and imipenem in an experimental peritonitis model caused by a Staphylococcus aureus strain with reduced susceptibility to vancomycin.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Ascitic Fluid; Bacteremia; Bacterial Load; Disease Models, Animal; Drug Therapy, Combination; Female; Fosfomycin; Humans; Imipenem; Linezolid; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Oxazolidinones; Peritonitis; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2011 |
In vitro sensitivity and resistance of 46 Leptospira strains isolated from rats in the Philippines to 14 antimicrobial agents.
Topics: Amphotericin B; Ampicillin; Animals; Anti-Bacterial Agents; Cefotaxime; Ciprofloxacin; Doxycycline; Erythromycin; Fluorouracil; Fosfomycin; Leptospira; Microbial Sensitivity Tests; Neomycin; Philippines; Rats; Sulfamethoxazole; Trimethoprim; Vancomycin | 2010 |
[City type MRSA infection].
Topics: Adult; Anti-Bacterial Agents; Clindamycin; Female; Fosfomycin; Humans; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Vancomycin | 2010 |
Emergence of vancomycin-resistant Staphylococcus aureus identified in the Tlemcen university hospital (North-West Algeria).
Topics: Adult; Aged; Algeria; Aminoglycosides; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Cross Infection; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Female; Fosfomycin; Gentamicins; Hospitals, University; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Rifampin; Staphylococcal Infections; Surgical Wound Infection; Vancomycin; Vancomycin Resistance | 2011 |
Successful management of methicillin-resistant Staphylococcus aureus bacteremia unresponsive to Vancomycin by adding fosfomycin: a case report.
Topics: Anti-Bacterial Agents; Drug Therapy, Combination; Female; Fosfomycin; Humans; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Sepsis; Vancomycin | 2012 |
Fosfomycin synergy in vitro with amoxicillin, daptomycin, and linezolid against vancomycin-resistant Enterococcus faecium from renal transplant patients with infected urinary stents.
Topics: Acetamides; Amoxicillin; Anti-Bacterial Agents; Daptomycin; Drug Synergism; Enterococcus faecium; Fosfomycin; Gram-Positive Bacterial Infections; Humans; Kidney Transplantation; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Stents; Urinary Tract; Urinary Tract Infections; Vancomycin; Vancomycin Resistance | 2013 |
Comparative study of the mutant prevention concentrations of vancomycin alone and in combination with levofloxacin, rifampicin and fosfomycin against methicillin-resistant Staphylococcus epidermidis.
Topics: Anti-Bacterial Agents; Drug Synergism; Drug Therapy, Combination; Fosfomycin; Genes, Bacterial; Humans; Levofloxacin; Methicillin Resistance; Microbial Sensitivity Tests; Mutation; Rifampin; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 2013 |
Activities of fosfomycin and rifampin on planktonic and adherent Enterococcus faecalis strains in an experimental foreign-body infection model.
Topics: Acetamides; Ampicillin; Animals; Anti-Bacterial Agents; Bacterial Adhesion; Biofilms; Calorimetry; Daptomycin; Disease Models, Animal; Drug Therapy, Combination; Enterococcus faecalis; Foreign Bodies; Fosfomycin; Gentamicins; Gram-Positive Bacterial Infections; Guinea Pigs; Linezolid; Male; Microbial Sensitivity Tests; Oxazolidinones; Rifampin; Vancomycin | 2014 |
The fosfomycin resistance gene fosB3 is located on a transferable, extrachromosomal circular intermediate in clinical Enterococcus faecium isolates.
Topics: Anti-Bacterial Agents; Conjugation, Genetic; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Fosfomycin; Genes, Bacterial; Microbial Sensitivity Tests; Vancomycin | 2013 |
Vertebral osteomyelitis caused by vancomycin-tolerant methicillin-resistant Staphylococcus aureus bacteremia: Experience with teicoplanin plus fosfomycin combination therapy.
Topics: Aged, 80 and over; Bacteremia; Drug Combinations; Female; Fosfomycin; Humans; Magnetic Resonance Imaging; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Osteomyelitis; Spine; Staphylococcal Infections; Teicoplanin; Vancomycin; Vancomycin Resistance | 2016 |
Fosfomycin resistance among vancomycin-resistant enterococci owing to transfer of a plasmid harbouring the fosB gene.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Conjugation, Genetic; DNA Transposable Elements; Drug Resistance, Bacterial; Enterococcus; Fosfomycin; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids; Proto-Oncogene Proteins c-fos; Transposases; Vancomycin; Vancomycin Resistance | 2014 |
Evaluation of double- and triple-antibiotic combinations for VIM- and NDM-producing Klebsiella pneumoniae by in vitro time-kill experiments.
Topics: Aminoglycosides; Anti-Bacterial Agents; Aztreonam; beta-Lactamases; Ciprofloxacin; Colistin; Daptomycin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Fosfomycin; In Vitro Techniques; Klebsiella pneumoniae; Lipoglycopeptides; Meropenem; Microbial Sensitivity Tests; Minocycline; Rifampin; Thienamycins; Tigecycline; Vancomycin | 2014 |
Liquid dextran does not increase the elution rate of different antibiotics from bone cement.
Topics: Acrylic Resins; Anti-Bacterial Agents; Bacillus subtilis; Bone Cements; Clindamycin; Dextrans; Diffusion; Disk Diffusion Antimicrobial Tests; Fosfomycin; Gentamicins; Methicillin-Resistant Staphylococcus aureus; Methylmethacrylates; Vancomycin | 2015 |
Efficacy of fosfomycin compared to vancomycin in treatment of implant-associated chronic methicillin-resistant Staphylococcus aureus osteomyelitis in rats.
Topics: Animals; Anti-Bacterial Agents; Fosfomycin; Male; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Osteomyelitis; Rats; Rats, Sprague-Dawley; Staphylococcal Infections; Vancomycin | 2014 |
Prevalence of the fosfomycin-resistance determinant, fosB3, in Enterococcus faecium clinical isolates from China.
Topics: Bacterial Proteins; China; Drug Resistance, Bacterial; Enterococcus faecium; Fosfomycin; Gram-Positive Bacterial Infections; Humans; Vancomycin | 2014 |
Prolonged treatment with large doses of fosfomycin plus vancomycin and amikacin in a case of bacteraemia due to methicillin-resistant Staphylococcus epidermidis and IMP-8 metallo-β-lactamase-producing Klebsiella oxytoca.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Coinfection; Fosfomycin; Humans; Klebsiella Infections; Klebsiella oxytoca; Male; Methicillin Resistance; Staphylococcal Infections; Staphylococcus epidermidis; Treatment Outcome; Vancomycin | 2015 |
Impact of antibiotics with various target sites on the metabolome of Staphylococcus aureus.
Topics: Ampicillin; Anti-Bacterial Agents; Cell Wall; Ciprofloxacin; Erythromycin; Fosfomycin; Metabolic Networks and Pathways; Metabolome; Peptidoglycan; Staphylococcus aureus; Vancomycin | 2014 |
Efficacy of combined vancomycin and fosfomycin against methicillin-resistant Staphylococcus aureus in biofilms in vivo.
Topics: Animals; Anti-Bacterial Agents; Biofilms; C-Reactive Protein; Drug Synergism; Fosfomycin; Leukocyte Count; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Rats; Rats, Sprague-Dawley; Staphylococcal Infections; Vancomycin | 2014 |
Fosfomycin plus β-Lactams as Synergistic Bactericidal Combinations for Experimental Endocarditis Due to Methicillin-Resistant and Glycopeptide-Intermediate Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Aortic Valve; Area Under Curve; Ceftriaxone; Drug Administration Schedule; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Endocarditis, Bacterial; Fosfomycin; Gene Expression; Imipenem; Infusion Pumps; Methicillin-Resistant Staphylococcus aureus; Penicillin-Binding Proteins; Protein Isoforms; Rabbits; Staphylococcal Infections; Vancomycin | 2016 |
VISLISI trial, a prospective clinical study allowing identification of a new metalloprotease and putative virulence factor from Staphylococcus lugdunensis.
Topics: Adult; Aged; Aged, 80 and over; Amino Acid Sequence; Aminoglycosides; Base Sequence; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Erythromycin; Female; Fluoroquinolones; Follow-Up Studies; Fosfomycin; Fusidic Acid; Humans; Male; Metalloproteases; Methicillin; Middle Aged; Phosphonoacetic Acid; Prospective Studies; Sequence Analysis, DNA; Staphylococcal Infections; Staphylococcus lugdunensis; Vancomycin; Virulence Factors | 2017 |
High-Level Fosfomycin Resistance in Vancomycin-Resistant Enterococcus faecium.
Topics: Alkyl and Aryl Transferases; Amino Acid Substitution; Anti-Bacterial Agents; Bacterial Proteins; Drug Resistance, Bacterial; Enterococcus faecium; Fosfomycin; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Mutation; Pennsylvania; Vancomycin | 2017 |
Metabolic Mitigation of Staphylococcus aureus Vancomycin Intermediate-Level Susceptibility.
Topics: Adaptation, Physiological; Anti-Bacterial Agents; Citric Acid Cycle; Drug Combinations; Drug Synergism; Fosfomycin; Humans; Mercaptopurine; Microbial Sensitivity Tests; Pentose Phosphate Pathway; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2018 |
Synergistic combination of two antimicrobial agents closing each other's mutant selection windows to prevent antimicrobial resistance.
Topics: Anti-Bacterial Agents; Culture Media; Doxycycline; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Fosfomycin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mutation; Ofloxacin; Roxithromycin; Vancomycin | 2018 |
Synergistic Activities of Colistin Combinations with Meropenem, Sulbactam, Minocycline, Disodium Fosfomycin, or Vancomycin Against Different Clones of Carbapenem-Resistant
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacteriological Techniques; Carbapenems; Colistin; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Fosfomycin; Humans; Meropenem; Minocycline; Sulbactam; Vancomycin | 2020 |
CRISPR-Cas9 modified bacteriophage for treatment of Staphylococcus aureus induced osteomyelitis and soft tissue infection.
Topics: Animals; Anti-Bacterial Agents; Bacteriophages; Biofilms; CRISPR-Cas Systems; Disease Models, Animal; Female; Fosfomycin; Gene Editing; Longitudinal Studies; Osteomyelitis; Rats; Rats, Sprague-Dawley; Soft Tissue Infections; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2019 |
In vitro synergy with fosfomycin plus doxycyclin against linezolid and vancomycin-resistant Enterococcus faecium.
Topics: Anti-Bacterial Agents; Enterococcus faecium; Fosfomycin; Linezolid; Vancomycin | 2020 |
Evaluation of fosfomycin combined with vancomycin against vancomycin-resistant coagulase negative staphylococci.
Topics: Anti-Bacterial Agents; Bacteriological Techniques; Coagulase; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Synergism; Fosfomycin; Genotype; Humans; Oxacillin; Phenotype; Vancomycin; Vancomycin Resistance | 2020 |
Efficacy of Vancomycin with Fosfomycin against Vancomycin-Resistant Enterococcus Strains Using Agar Dilution Method.
Topics: Agar; Anti-Bacterial Agents; Enterococcus faecium; Fosfomycin; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Vancomycin | 2021 |
Addition of Oral Fosfomycin to Antimicrobial Salvage Therapy for Persistent Vancomycin-Resistant Enterococcal Bacteremia.
Topics: Anti-Bacterial Agents; Bacteremia; Fosfomycin; Gram-Positive Bacterial Infections; Humans; Salvage Therapy; Vancomycin | 2022 |
Influence of daptomycin dose and fosfomycin susceptibility on outcome of vancomycin-resistant Enterococcus faecium bloodstream infections treated with daptomycin and fosfomycin combination.
Topics: Anti-Bacterial Agents; Bacteremia; Daptomycin; Enterococcus faecium; Fosfomycin; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Monobactams; Prospective Studies; Vancomycin; Vancomycin-Resistant Enterococci | 2022 |
The evaluation of antibiotic susceptibility pattern and associated risk factors of UTI in tertiary care hospital of Peshawar.
Topics: Amikacin; Anti-Bacterial Agents; Escherichia coli; Female; Fosfomycin; Humans; Imipenem; Klebsiella pneumoniae; Linezolid; Male; Meropenem; Pseudomonas aeruginosa; Risk Factors; Tertiary Care Centers; Urinary Tract Infections; Vancomycin | 2022 |
In vitro activity of fosfomycin alone and in combination against Staphylococcus aureus with reduced susceptibility or resistance to methicillin, vancomycin, daptomycin or linezolid.
Topics: Anti-Bacterial Agents; Cefazolin; Ceftaroline; Daptomycin; Fosfomycin; Humans; Linezolid; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2022 |
Cerebrospinal fluid penetration of fosfomycin in patients with ventriculitis: an observational study.
Topics: Adult; Anti-Bacterial Agents; Cerebral Ventriculitis; Cerebrospinal Fluid; Fosfomycin; Humans; Meropenem; Vancomycin | 2023 |